Similarly, LTβR agonists and LIGHT induced HEV and TLS formation, increased lymphocyte filtration, and enhanced the anti-tumor effects of ICI, prolonging the survival period of tumor-bearing mice [47–49]. The gene discussed is LTBR; the disease is neoplasm.